BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1482356)

  • 1. Kinetics and organ distribution of [14C]-sialic acid-GM3 and [3H]-sphingosine-GM1 after intravenous injection in rats.
    Dumontet C; Rebbaa A; Portoukalian J
    Biochem Biophys Res Commun; 1992 Dec; 189(3):1410-6. PubMed ID: 1482356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The sialic acid residue of exogenous GM1 ganglioside is recycled for biosynthesis of sialoglycoconjugates in rat liver.
    Ghidoni R; Trinchera M; Sonnino S; Chigorno V; Tettamanti G
    Biochem J; 1987 Oct; 247(1):157-64. PubMed ID: 3689344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for sialidase hydrolyzing gangliosides GM2 and GM1 in rat liver plasma membrane.
    Miyagi T; Tsuiki S
    FEBS Lett; 1986 Oct; 206(2):223-8. PubMed ID: 3758350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism of exogenous gangliosides GM1 and chemically modified GM1 in mice.
    Ogura K; Handa S
    J Biochem; 1988 Jul; 104(1):87-92. PubMed ID: 3220834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of isotopically radiolabelled GM3 ganglioside to study metabolic alterations in Salla disease.
    Chigorno V; Valsecchi M; Nicolini M; Sonnino S
    Indian J Biochem Biophys; 1997; 34(1-2):150-6. PubMed ID: 9343943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic processing of gangliosides by normal and Salla human fibroblasts in culture. A study performed by administering radioactive GM3 ganglioside.
    Chigorno V; Tettamanti G; Sonnino S
    J Biol Chem; 1996 Sep; 271(36):21738-44. PubMed ID: 8702969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recycling of glucosylceramide and sphingosine for the biosynthesis of gangliosides and sphingomyelin in rat liver.
    Trinchera M; Ghidoni R; Sonnino S; Tettamanti G
    Biochem J; 1990 Sep; 270(3):815-20. PubMed ID: 2241913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Occurrence of glycosylation and deglycosylation of exogenously administered ganglioside GM1 in mouse liver.
    Ghidoni R; Sonnino S; Chigorno V; Venerando B; Tettamanti G
    Biochem J; 1983 Aug; 213(2):321-9. PubMed ID: 6615438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uptake, metabolism and excretion of orally and intravenously administered, 14C- and 3H-labeled N-acetylneuraminic acid mixture in the mouse and rat.
    Nöhle U; Schauer R
    Hoppe Seylers Z Physiol Chem; 1981 Nov; 362(11):1495-506. PubMed ID: 7030915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Approaches in the study of ganglioside metabolism.
    Tettamanti G; Ghidoni R; Sonnino S; Chigorno V; Venerando B; Giuliani A; Fiorilli A
    Adv Exp Med Biol; 1984; 174():273-84. PubMed ID: 6377848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid internalization of exogenous ganglioside GM3 and its metabolism to ceramide in human myelogenous leukemia HL-60 cells compared with control ganglioside GM1.
    Nakamura M; Tsunoda A; Furukawa Y; Sakai T; Saito M
    FEBS Lett; 1997 Jan; 400(3):350-4. PubMed ID: 9009229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GM3 ganglioside in various tissues of rabbit. Tissue-specific distribution of N-glycolylneuraminic acid-containing GM31.
    Iwamori M; Nagai Y
    J Biochem; 1978 Dec; 84(6):1609-15. PubMed ID: 739008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disposition of exogenous tritium-labelled GM1lactone in the rat.
    Bellato P; Milan F; Facchinetti E; Toffano G
    Neurochem Int; 1992 Apr; 20(3):359-64. PubMed ID: 1304330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison and Possible Binding Orientations of SARS-CoV-2 Spike N-Terminal Domain for Gangliosides GM3 and GM1.
    Das T; Mukhopadhyay C
    J Phys Chem B; 2023 Aug; 127(31):6940-6948. PubMed ID: 37523476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation of various lysogangliosides including lyso-fucosyl GM1 and delayed extraction matrix-assisted laser desorption ionization time-of-flight mass spectrometric analysis.
    Taketomi T; Hara A; Uemura K; Kurahashi H; Sugiyama E
    J Biochem; 1997 Feb; 121(2):264-9. PubMed ID: 9089399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gangliosides of liver tumors induced by N-2-fluorenylacetamide. I. Ganglioside alterations in liver tumorigenesis and normal development.
    Merritt WD; Richardson CL; Keenan TW; Morré DJ
    J Natl Cancer Inst; 1978 Jun; 60(6):1313-27. PubMed ID: 206706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incorporation and metabolism of exogenous GM1 ganglioside in rat liver.
    Ghidoni R; Trinchera M; Venerando B; Fiorilli A; Sonnino S; Tettamanti G
    Biochem J; 1986 Jul; 237(1):147-55. PubMed ID: 3800874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gangliosides in normal and cataractous lenses of several species.
    Sarkar CP; Cenedella RJ
    Biochim Biophys Acta; 1982 Jun; 711(3):503-8. PubMed ID: 7104379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ganglioside incorporation and release by the isolated perfused rat liver.
    Kivatinitz SC; Miglio A; Ghidoni R
    Biochem J; 1991 Mar; 274 ( Pt 2)(Pt 2):581-5. PubMed ID: 2006919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution of gangliosides, GM1 and GM3, in the rat oviduct.
    Choo YK
    Mol Cells; 1999 Feb; 9(1):56-60. PubMed ID: 10102572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.